Early research (Phase 1)Study completedNCT01730118What this trial is testingAd/HER2/Neu Dendritic Cell Cancer Vaccine TestingWho this might be right forBreast NeoplasmsBreast CancerAdenocarcinomas+1 more National Cancer Institute (NCI) 33